Parties d'ouvrages collectifs (4)
  1. 1. Bockstael, O., Foust, K., Kaspar, B., & Tenenbaum, L. (2010). rAAV for CNS. In R. Snyder & P. Moullier (Eds.), Adeno-Associated virus: methods and protocols (p. chapter 7). Humana Press.(Methods in molecular biology).
  2. 2. Lehtonen, E., & Tenenbaum, L. (2003). Adeno-associated viral vectors. In D. Lachtman (Ed.), Viral vectors for treating diseases of the nervous system (pp. 65-98). London-San Diego: Academic Press.(International review of neurobiology, 55).
  3. 3. Tenenbaum, L. (2000). Gene therapy of neurodegenerative and demyelinating diseases. In G. Gregoriadis & B. McCormack (Eds.), Targeting of drugs: strategies for gene constructs and delivery (pp. 53-68). Amsterdam, Netherlands: Ios Press.(Nato Science series : Serie A : Life science, 323).
  4. 4. Tenenbaum, L., & Peters, E. (1996). Gene delivery using adeno-associated virus. In D. Lachtman (Ed.), Genetic manipulation of the nervous system (pp. 73-97). London-San Diego: Academic-Press.
    5.   Articles dans des revues avec comité de lecture (44)
  5. 1. Dwir, D., Giangreco, B., Xin, L., Tenenbaum, L., Cabungcal, J. H., Steullet, P., Goupil, A., Cleusix, M., Jenni, R., Chtarto, A., Baumann, P. S., Klauser, P., Conus, P., Tirouvanziam, R., Cuenod, M., & Do, K. K. (2020). MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients. Molecular psychiatry, 25(11), 3105. doi:10.1038/s41380-019-0393-5
  6. 2. Bachoud-Lévi, A.-C., Schramm, C., Remy, P., Aubin, G., Blond, S., Bocket, L., Brugières, P., Calvas, F., Calvier, E., Cassim, F., Challine, D., Gagou, C. S., De Langavant, L. C., Collier, F., Cottencin, O., David, P., Damier, P., Delliaux, M., Delmaire, C., Delval, A., Démonet, J., Descamps, P., Gaura, V., Gohier, B., Goldman, S., Haddad, B., Izopet, J., Jeny, R., Kerr-Conte, J., Krystowiak, P., Lalanne, C., Lavisse, S., Lefaucheur, J., Lemoine, L., Levivier, M., Lotterie, J., Lunel‐Fabiani, F., Maison, P., Massager, N., Massart, R., Menei, P., Montero‐Menei, C., Neveu, I., Parant, O., Pautot, V., Payoux, P., Péréon, Y., Rialland, A., Rosser, A., Rouard, H. H., Schmitz, D., Simonetta‐Moreau, M., Simonin, C., Slama, H., Sol, J., Supiot, F., Tanguy, J., Tenenbaum, L., Verny, C., Youssov, K., Peschanski, M., Audureau, E., Palfi, S., & Hantraye, P. (2020). Human Fetal Cell Therapy in Huntington's Disease: A Randomized, Multicenter, Phase II Trial. Movement disorders, 35(8), 1323-1335. doi:10.1002/mds.28201
  7. 3. Dwir, D., Giangreco, B., Xin, L., Tenenbaum, L., Cabungcal, J. H., Steullet, P., Goupil, A., Cleusix, M., Jenni, R., Chtarto, A., Baumann, P. S., Klauser, P., Conus, P., Tirouvanziam, R., Cuenod, M., & Do, K. K. (2020). Correction: MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients. Molecular psychiatry. doi:10.1038/s41380-020-0716-6
  8. 4. Liu, S., Blesch, A., Sandner, B., Schackel, T., Nicholson, L. S., Chtarto, A., Tenenbaum, L., Puttagunta, R., Müller, R., & Weidner, N. (2017). Regulated viral BDNF delivery in combination with Schwann cells promotes axonal regeneration through capillary alginate hydrogels after spinal cord injury. Acta Biomaterialia, 60, 167-180. doi:10.1016/j.actbio.2017.07.024
  9. 5. Bazewicz, M., Draganova, D., Makhoul, M., Chtarto, A., Elmaleh, V., Tenenbaum, L., Caspers, L., Bruyns, C., & Willermain, F. (2016). Effect of SOCS1 overexpression on RPE cell activation by proinflammatory cytokines. Neuroscience letters, 630, 209-215. doi:10.1016/j.neulet.2016.07.054
  10. 6. Barroso-Chinea, P., González-Hernández, T., Cruz-Muros, I., Afonso-Oramas, D., Castro-Hernández, J., Salas-Hernández, J., Chtarto, A., Luis-Ravelo, D., Humbert-Claude, M., & Tenenbaum, L. (2016). Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system. Neurobiology of disease, 88, 44-54. doi:10.1016/j.nbd.2016.01.002
  11. 7. Chtarto, A., Humbert-Claude, M., Bockstael, O., Das, A. A., Boutry, S., Breger, L. L., Klaver, B., Melas, C., Barroso-Chinea, P., González-Hernández, T., Muller, R. N., De Witte, O., Levivier, M., Lundberg, C., Berkhout, B., & Tenenbaum, L. (2016). A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses. Molecular therapy. Methods & clinical development, 5, 16027. doi:10.1038/mtm.2016.27
  12. 8. Bockstael, O., Tenenbaum, L., Dalkara, D., Melas, C., De Witte, O., Levivier, M., & Chtarto, A. (2014). Intracisternal delivery of NFκB-inducible scAAV2/9 reveals locoregional  euroinflammation induced by systemic kainic acid treatment. Frontiers in Molecular Neuroscience, 7(DEC), 92. doi:10.3389/fnmol.2014.00092
    13. << Précédent 1 2 3 4 5 Suivant >>